Recombinant outer membrane vesicles as a novel adjuvant for a malaria vaccine

Ended Definitive Contract Awarded Last action

Contract number
75N93018C00038
Awardee
Awarding agency
Obligated
$450,000

Award facts

Contract value 100% obligated
$450,000.00 Current and potential, with all options
Completion date 100% complete
Current and potential, with all options
Set-aside
Total Small Business
Competition
Full and Open Competition after exclusion of sources · 7 offers Negotiated Proposal / Quote
Pricing
Firm Fixed Price
Place of performance
Lowell, MA 01852, USA
Research
SBIR Program Phase I Action

Award details come from SAM.gov/FPDS.

Transactions

Action Obligated Date
Other Administrative Action P00002 · To issue a no additional cost extension from 02/18/2021 to 06/15/2021. $0
Other Administrative Action P00001 · To issue a no additional cost extension to the contract as well as incorporate far CLAUSES52.204-25, 52.244-6 and 52.204-21. The contract completion date is… $0
Original award $450,000

About this award

This is a $450,000.00 Small Business Innovation Research (SBIR) Phase I contract awarded by the National Institutes of Health (NIH) to Versatope Therapeutics Inc., a for-profit biotechnology company. The contract is for the development of a novel adjuvant for a malaria vaccine, using Versatope's recombinant outer membrane vesicle (ROMV) technology. The original solicitation was part of the NIH and Centers for Disease Control and Prevention (CDC) SBIR Program, which seeks to stimulate technological innovation and increase the commercial application of federally-supported research. The contract is a definitive, firm fixed-price agreement to advance Versatope's work on ROMV-based vaccines for infectious diseases like malaria. Versatope has also received several other SBIR grants from NIH and CDC to develop innovative vaccine candidates.

Quick answers

Who was awarded contract 75N93018C00038?

75N93018C00038 was awarded to Versatope Therapeutics Inc. by National Institute of Allergy and Infectious Diseases (National Institutes of Health) on August 22, 2018.

How much is contract 75N93018C00038 worth?

The government has obligated $450,000 on 75N93018C00038.

Was contract 75N93018C00038 competed?

The extent of competition for 75N93018C00038 was full and open competition after exclusion of sources. The government received 7 offers. It was set aside: Total Small Business.

On GovTribe

See this award's full record

  • Every transaction and funding action
  • The awardee's other awards and teaming partners
  • Similar awards and recompete opportunities
  • Ask GovTribe AI about this award